Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Cattrini

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Clinical Genitourinary Cancer|June 5, 2019
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based StudyCarlo Cattrini, Luigi Cerbone, Alessandra Rubagotti, et al.
British Journal of Cancer|October 27, 2020
Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancerRebeca Lozano, Elena Castro, Isabel M Aragón, et al.
Therapeutic Advances in Urology|November 4, 2021
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysisCarlo Cattrini, Carlo Messina, Chiara Airoldi, et al.
Journal of Oncology|September 23, 2020
BRCA Mutations in Prostate Cancer: Prognostic and Predictive ImplicationsCarlo Messina, Carlo Cattrini, Davide Soldato, et al.
International Journal of Molecular Sciences|July 4, 2018
A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate CancerMatteo Capaia, Ilaria Granata, Mario Guarracino, et al.
Cancers|October 7, 2020
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate CancerCarlo Cattrini, Davide Soldato, Alessandra Rubagotti, et al.
Biomolecules|January 22, 2021
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational InsightsFederica Biello, Francesca Platini, Francesca D'Avanzo, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomesAlessia Cavo, Alessandra Rubagotti, Elisa Zanardi, et al.
The Oncologist|December 21, 2020
Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not DeferrablePaolo Pedrazzoli, David Rondonotti, Carlo Cattrini, et al.
Clinical Genitourinary Cancer|September 2, 2018
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical OutcomeCarlo Cattrini, Alessandra Rubagotti, Pier Vitale Nuzzo, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Clinical Genitourinary Cancer|June 5, 2019
Prognostic Variables in Patients With Non-metastatic Small-cell Neuroendocrine Carcinoma of the Bladder: A Population-Based StudyCarlo Cattrini, Luigi Cerbone, Alessandra Rubagotti, et al.
British Journal of Cancer|October 27, 2020
Genetic aberrations in DNA repair pathways: a cornerstone of precision oncology in prostate cancerRebeca Lozano, Elena Castro, Isabel M Aragón, et al.
Therapeutic Advances in Urology|November 4, 2021
Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysisCarlo Cattrini, Carlo Messina, Chiara Airoldi, et al.
Journal of Oncology|September 23, 2020
BRCA Mutations in Prostate Cancer: Prognostic and Predictive ImplicationsCarlo Messina, Carlo Cattrini, Davide Soldato, et al.
International Journal of Molecular Sciences|July 4, 2018
A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate CancerMatteo Capaia, Ilaria Granata, Mario Guarracino, et al.
Cancers|October 7, 2020
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate CancerCarlo Cattrini, Davide Soldato, Alessandra Rubagotti, et al.
Biomolecules|January 22, 2021
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational InsightsFederica Biello, Francesca Platini, Francesca D'Avanzo, et al.
Therapeutic Advances in Medical Oncology|February 1, 2018
Abiraterone acetate and prednisone in the pre- and post-docetaxel setting for metastatic castration-resistant prostate cancer: a mono-institutional experience focused on cardiovascular events and their impact on clinical outcomesAlessia Cavo, Alessandra Rubagotti, Elisa Zanardi, et al.
The Oncologist|December 21, 2020
Metastatic Mediastinal Germ-Cell Tumor and Concurrent COVID-19: When Chemotherapy Is Not DeferrablePaolo Pedrazzoli, David Rondonotti, Carlo Cattrini, et al.
Clinical Genitourinary Cancer|September 2, 2018
Overexpression of Periostin in Tumor Biopsy Samples Is Associated With Prostate Cancer Phenotype and Clinical OutcomeCarlo Cattrini, Alessandra Rubagotti, Pier Vitale Nuzzo, et al.
Pageof 6